BE629596A - Pharmaceutical preparations acting on the central nervous system and their manufacture - Google Patents

Pharmaceutical preparations acting on the central nervous system and their manufacture

Info

Publication number
BE629596A
BE629596A BE629596A BE629596A BE629596A BE 629596 A BE629596 A BE 629596A BE 629596 A BE629596 A BE 629596A BE 629596 A BE629596 A BE 629596A BE 629596 A BE629596 A BE 629596A
Authority
BE
Belgium
Prior art keywords
manufacture
nervous system
central nervous
pharmaceutical preparations
preparations acting
Prior art date
Application number
BE629596A
Other languages
Dutch (nl)
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of BE629596A publication Critical patent/BE629596A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE629596A 1962-03-14 1963-03-14 Pharmaceutical preparations acting on the central nervous system and their manufacture BE629596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL275964 1962-03-14

Publications (1)

Publication Number Publication Date
BE629596A true BE629596A (en) 1963-10-21

Family

ID=19753670

Family Applications (1)

Application Number Title Priority Date Filing Date
BE629596A BE629596A (en) 1962-03-14 1963-03-14 Pharmaceutical preparations acting on the central nervous system and their manufacture

Country Status (4)

Country Link
BE (1) BE629596A (en)
ES (1) ES285768A1 (en)
FR (1) FR2852M (en)
GB (1) GB1041861A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
GB8823605D0 (en) * 1988-10-07 1988-11-16 Merck Sharp & Dohme Therapeutic agents
AU2003263393A1 (en) * 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
JP2006506379A (en) 2002-10-23 2006-02-23 グレンマーク・ファーマシューティカルズ・リミテッド Novel tricyclic compounds useful for the treatment of inflammatory and allergic diseases: methods for their preparation and pharmaceutical compositions containing them
PT1620429E (en) 2003-04-11 2009-04-28 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
CA2583497A1 (en) 2004-10-13 2006-04-20 Glenmark Pharmaceuticals S.A. Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
UA88795C2 (en) 2004-12-17 2009-11-25 Гленмарк Фармасьютікалс С.А. Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
AP2334A (en) 2004-12-17 2011-12-06 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflamatory and allergic disorders.

Also Published As

Publication number Publication date
ES285768A1 (en) 1963-07-01
GB1041861A (en) 1966-09-07
FR2852M (en) 1964-10-19

Similar Documents

Publication Publication Date Title
CH424364A (en) Herbicides
NL139053B (en) RESPIRATOR.
CH472839A (en) Insecticide and acaricide
FR2513M (en) Anti-inflammatory preparations.
NL150336B (en) RESPIRATOR.
FR1358920A (en) Cone crusher or crusher
FR3041M (en) Vitamin preparations.
BE629596A (en) Pharmaceutical preparations acting on the central nervous system and their manufacture
FR1514M (en) New therapeutic preparations.
BR6464845D0 (en) PRAGUICIDAL PREPARATIONS
AT257264B (en) Herbicides
NL154342B (en) CONNECTION SYSTEM FOR IMPORT AND EXPORT AGENTS.
AT257265B (en) Herbicides
FR3168M (en) New androgenic and anabolic drugs.
CH437910A (en) Herbicides means
BR6238314D0 (en) CONTROLLED RELEASE DRUGS
FR1444489A (en) New coloring matters and their preparation
FR1405494A (en) 1.4-Benzodioxanes and their preparation
AT240223B (en) Cone control system
CH413484A (en) Pesticide
FR1984M (en) Neuropsychic regulator drug.
FR1287605A (en) Headquarters or similar
FR1268M (en) Antimitotic and antiviral drug.
FR1346366A (en) Audiometer controllers
FR2456M (en) Hemotherapic drug.